[1]
Abola, P. and Jabishvili, G. 2025. Incidence of Adverse and Safety Events in Individuals with Parkinson’s Disease Treated with Catechol-O-Methyltransferase Inhibitor Opicapone as an Add-On to Levodopa Treatment: A Systematic Review and Meta-Analysis. Prospects in Pharmaceutical Sciences. 2025 (Early Access) (Aug. 2025). DOI:https://doi.org/10.56782/pps.563.